JC THEDOG
24 posts


@andrew_nfx No surprise at all that he found more success using negative RR with prop firms. You just have to look at rules such as the consistency rules. These sort of rules favour negative RR traders much more
English

I met a trader in Dubai who was doing $80k/month in prop firm payouts.
He showed me his stats.
71% win rate.
Average RR: 0.8R to 1.2R.
I asked him why such low risk-reward.
'Bro, I tried the 1:3RR+ thing for 2 years. Blew 40+ accounts. My win rate was 25%. I'd have 8-10 losing trades in a row and couldn't handle it mentally.'
'Then I switched to taking quick profits. 1:1 mostly. Sometimes less if price shows weakness.'
'My win rate jumped to 70%+.'
He was running $2.8M in combined funding across 8 accounts.
Some months he'd make 1%. Some months 5%.
But he was consistent.
And the psychology was easier.
Winning 7 out of 10 trades feels completely different than winning 3 out of 10.
Even if the math says they're equal.
Your brain doesn't care about math during a 12-trade losing streak.
He told me:
'I don't need to be right about where price is going long-term. I just need to be right about the next 10-15 pips. That's it.'
Most traders are chasing these huge runners because someone on YouTube told them that's what 'real traders' do.
Meanwhile this guy is taking home $80k/month with 0.8-1.2R trades.
You don't need massive risk-reward to make serious money.
You need capital + consistency + a win rate you can actually maintain.
Low RR with high win rate will always beat high RR with low win rate when it comes to prop firm payouts.
English
JC THEDOG retweetledi

.@Aubrai_ doesn't just answer questions -> it downloads datasets, runs analysis, and finds what researchers missed.
We gave it a link to DrugAge.
It extracted 372 mouse studies, found 4 of 7 SENS categories missing from the top 10 longevity compounds, and proposed a combination to fill the gaps.
One prompt. No preprocessing. 47 minutes.
Link: chat.aubr.ai/chats/65FsHdFh…

English

1/ @vitadao portfolio project VitaRNA saw its research validated by a new Nature study.
According to founder @Mykalt45, the study provides quantitative support for the therapeutic potential of targeting nonsense mutations in stem and immune cells, offering independent scientific grounding. 🧵⬇️
Michael Torres@Mykalt45
A new Nature study just mapped >16 million immune cells across 300+ people. The punchline: immune aging follows a predictable, programmable transcriptomic drift. Aging is software. Not entropy. @Molecule_sci @vitadao @BioProtocol 🔗 Paper: nature.com/articles/s4158…
English

@ahkyee @BioProtocol @ResearchHub why don't you mention the coin @vitadao don't find it interesting?
English

Decentralized science (DeSci) coins are not altcoins.
They are next-gen scientific infrastructures to accelerate human abundance and flourishing.
@BioProtocol @ResearchHub $BIO $RSC
English

@umairbattle @BioProtocol do you thinks that desci is the narrative in 2025\2026?
English

Who’s buying with me? $BIO
@BioProtocol
We need to hold our bags and not fade this project
It will be one of the biggest plays in the upcoming months if not weeks 🚀
DeSci is coming…
Bio-tech is the narrative 🧪

Cointelegraph@Cointelegraph
🔥 JUST IN: CZ says he donated $10M in $BNB to Vitalik’s open-source biotech efforts, calling it “just my little part.”
English

@tb_travis @stanfordhudson In the meantime, the only one flying is Archer.😟 +20%
English

We've got movement in Marina with $JOBY N545JX!
Joby's newest aircraft (📣May 6, 2025) showed up today over at the main hangar where flight testing occurs.
Great to see Joby delivering yet another 🛩️ to join the current fleet doing flight testing.
Credit🧐 @stanfordhudson

English

@JC87740916 @vitadao My friend 2025 by look history for the humanity for Bitcoin and cryptocurrency, just look Forbes, Donald trump say price for Bitcoin in $800k to en of 2025 (15t), meaby this price for $100 or $150 for vita it's a joke meaby go for $1000 I don't know, just the time can say this
English

𝙈𝙔 𝙋𝙊𝙍𝙏𝙁𝙊𝙇𝙄𝙊 𝙐𝙋𝘿𝘼𝙏𝙀
YTD returns: +23.8%
TOTAL RETURNS (Jan 2022)
Natan's portfolio: +55.7% ✅
*Benchmark: +21.3%
S&P500: +31.2%
My positions: $PDD $BABA $META $PYPL $MRNA $HOOD $BTG $EW $TMDX $CRSP $NIO
TRANSACTIONS:
🔴 Sold positions: -
🟢 New positions: -
ALLOCATION BY COUNTRY:
🇺🇸 US: 55%
🇨🇳 China: 39%
🇨🇦 Canada: 6%
Follow me: @nataninvesting
- - - - - - - - - - - - - - - - - - -
* 𝘉𝘦𝘯𝘤𝘩𝘮𝘢𝘳𝘬 𝘪𝘴 𝘤𝘢𝘭𝘤𝘶𝘭𝘢𝘵𝘦𝘥 𝘢𝘴 𝘢 𝘸𝘦𝘪𝘨𝘩𝘵𝘦𝘥 𝘢𝘷𝘦𝘳𝘢𝘨𝘦 𝘰𝘧 𝘵𝘩𝘦 𝘧𝘰𝘭𝘭𝘰𝘸𝘪𝘯𝘨 𝘳𝘦𝘵𝘶𝘳𝘯𝘴:
- 60% 𝘕𝘢𝘴𝘥𝘢𝘲 𝘊𝘰𝘮𝘱𝘰𝘴𝘪𝘵𝘦 𝘌𝘛𝘍
- 40% 𝘊𝘩𝘪𝘯𝘢 𝘐𝘯𝘵𝘦𝘳𝘯𝘦𝘵 𝘒𝘞𝘌𝘉 𝘌𝘛𝘍
** 𝘛𝘩𝘪𝘴 𝘱𝘰𝘴𝘵 𝘪𝘴 𝘧𝘰𝘳 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘢𝘯𝘥 𝘦𝘥𝘶𝘤𝘢𝘵𝘪𝘰𝘯𝘢𝘭 𝘱𝘶𝘳𝘱𝘰𝘴𝘦𝘴 𝘰𝘯𝘭𝘺.
𝘐'𝘮 𝘯𝘰𝘵 𝘢 𝘧𝘪𝘯𝘢𝘯𝘤𝘪𝘢𝘭 𝘢𝘥𝘷𝘪𝘴𝘰𝘳 and all the 𝘪𝘯𝘧𝘰𝘳𝘮𝘢𝘵𝘪𝘰𝘯 𝘤𝘰𝘯𝘵𝘢𝘪𝘯𝘦𝘥 𝘪𝘯 𝘵𝘩𝘪𝘴 𝘱𝘰𝘴𝘵 𝘪𝘴 𝘯𝘰𝘵 𝘧𝘪𝘯𝘢𝘯𝘤𝘪𝘢𝘭 𝘢𝘥𝘷𝘪𝘤𝘦.

English

@arny_trezzi È da qualche mese che la tengo d'occhio, secondo me è molto interessante..
Comunque preso palantir a 7$😍
Italiano

$MRNA thesis looks pretty similar to the $ABCL one.
Superior tech platform + rich pipeline at a discounted price.
Have you ever considered investing in Moderna?
Natan@nataninvesting
1. $MRNA is the most overlooked biotech in the world. Despite a 92% decline in stock value over the past 3 years, there is potential for a big turnaround. My thesis in a few points 👇🧵
English

Hey, I just got an extra 5.07433 VITA on @CoWSwap! 🐮💸
Start swapping on swap.cow.fi
English










